Unicorn Nest Logo

Fairmount Funds Management

fairmountfunds.com
Type

Hedge fund

Status

Active

Location

West Conshohocken, United States

Total investments

15

Average round size

122M

Portfolio companies

13

Lead investments

1

Follow on index

0.13

Exits

8

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
15
Lead investments
1
Exits
8
Follow on index
0.13
Investments by industry
  • Biotechnology (14)
  • Therapeutics (10)
  • Health Care (8)
  • Life Science (5)
  • Biopharma (4)
    • Show 4 more
Investments by region
  • United States (13)
  • France (1)
  • United Kingdom (1)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
71M
Group Appearance index
1.00
Avg. company exit year
4
Avg. multiplicator
1.89
Strategy success index
0.89

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Apogee Therapeutics 07 Dec 2022 Biotechnology, Medical, Life Science, Therapeutics Early Stage Venture 149M United States, California, San Francisco
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.